Status:
UNKNOWN
Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
African Institute for Health and Development
Makerere University
Conditions:
Schistosomiasis in Children
Social Acceptance
Eligibility:
All Genders
18-99 years
Brief Summary
Knowledge, acceptability and perception of paediatric schistosomiasis and its treatment will be explored through a social science-driven mixed-methods approach within three endemic countries: Kenya, U...
Detailed Description
In many African countries, the worm disease schistosomiasis, also known as bilharzia, is a serious problem that affects the health of many people. An estimated 50 million pre-school children in sub-Sa...
Eligibility Criteria
Inclusion
- within the targeted communities
- all key informant groups as described
- willing to participate voluntarily and to provide informed consent
Exclusion
- \- refusing to give informed consent, participating not voluntarily or their participation causing psycho-social distress or even harm to themselves or other community members
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT05350462
Start Date
December 1 2021
End Date
December 31 2025
Last Update
December 1 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Université Félix Houphouët-Boigny
Abidjan, Côte d’Ivoire
2
African Institute for Health and Development
Nairobi, Kenya
3
Makerere University
Kampala, Uganda